Merck & Co., Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Merck & Co., Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q4 2023.
  • Merck & Co., Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $1.44B, a 6.76% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.44B +$91M +6.76% Dec 31, 2023 10-K 2024-02-26
Q4 2022 $1.35B -$240M -15.1% Dec 31, 2022 10-K 2024-02-26
Q4 2021 $1.59B -$102M -6.04% Dec 31, 2021 10-K 2023-02-24
Q4 2020 $1.69B +$615M +57.3% Dec 31, 2020 10-K 2022-02-25
Q4 2019 $1.07B Dec 31, 2019 10-K 2021-02-25
Q3 2019 $1.09B Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $1.06B Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $1.1B Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.